The forecasted sold production of composite diagnostic or laboratory reagents in Finland shows a steady increase from €699.18 million in 2024 to €1011.5 million in 2028. Comparing the years, the values are:
● 2024: €699.18 million
● 2025: €778.43 million
● 2026: €856.9 million
● 2027: €934.57 million
● 2028: €1011.5 million
The year-on-year growth rate between 2024 and 2025 is 11.33%, between 2025 and 2026 is 10.08%, between 2026 and 2027 is 9.06%, and between 2027 and 2028 is 8.24%. The compounded annual growth rate (CAGR) over the five-year period from 2024 to 2028 is 9.69%.
As we move forward, key trends to watch for include advancements in diagnostic technology, increased demand for laboratory reagents spurred by heightened health awareness, and potential regulatory changes that might impact market dynamics.
